enVVeno Medical Corporation (NVNO) DCF Valuation

enVVeno Medical Corporation (NVNO) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

enVVeno Medical Corporation (NVNO) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Gain insight into your enVVeno Medical Corporation (NVNO) valuation analysis using our sophisticated DCF Calculator! Preloaded with real (NVNO) data, this Excel template enables you to adjust forecasts and assumptions to accurately determine the intrinsic value of enVVeno Medical Corporation.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 -100 0 0 0 -25 -25 -25 -25 -25
EBITDA -7.0 -8.8 -16.8 -24.5 -25.0 .0 .0 .0 .0 .0
EBITDA, % -22286.05 100 100 100 100 60 60 60 60 60
Depreciation .4 .4 .5 .5 .2 .0 .0 .0 .0 .0
Depreciation, % 1269.61 100 100 100 100 100 100 100 100 100
EBIT -7.4 -9.1 -17.2 -25.0 -25.2 .0 .0 .0 .0 .0
EBIT, % -23555.66 100 100 100 100 60 60 60 60 60
Total Cash 1.3 9.3 54.7 39.0 46.4 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 0 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 0 100 100 100 100 80 80 80 80 80
Accounts Payable 1.2 1.4 .6 .6 .4 .0 .0 .0 .0 .0
Accounts Payable, % 3908.68 100 100 100 100 100 100 100 100 100
Capital Expenditure -.4 -.2 -.4 -.1 .0 .0 .0 .0 .0 .0
Capital Expenditure, % -1164.71 100 100 100 100 -20 -20 -20 -20 -20
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -7.4 -8.9 -16.9 -24.7 -25.2 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -6.1 -8.5 -17.6 -24.2 -25.3 -.4 .0 .0 .0 .0
WACC, % 10 9.99 10 10 10 10 10 10 10 10
PV UFCF
SUM PV UFCF -.4
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value 0
Net Debt -2
Equity Value 2
Diluted Shares Outstanding, MM 12
Equity Value Per Share 0.15

What You Will Get

  • Real NVNO Financials: Access to historical and projected data for precise valuation.
  • Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
  • Dynamic Calculations: Intrinsic value and NPV are computed in real-time.
  • Scenario Analysis: Evaluate various scenarios to assess enVVeno Medical's future performance.
  • User-Friendly Design: Designed for professionals while remaining approachable for newcomers.

Key Features

  • 🔍 Real-Life NVNO Financials: Pre-filled historical and projected data for enVVeno Medical Corporation (NVNO).
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate enVVeno's intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize enVVeno's valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  • 1. Access the Template: Download and open the Excel file containing enVVeno Medical Corporation’s (NVNO) preloaded data.
  • 2. Modify Assumptions: Adjust key inputs such as growth rates, WACC, and capital expenditures as needed.
  • 3. Analyze Results in Real-Time: The DCF model automatically computes intrinsic value and NPV based on your inputs.
  • 4. Explore Scenarios: Evaluate various forecasts to understand different valuation possibilities.
  • 5. Present with Assurance: Deliver professional valuation insights to reinforce your decision-making process.

Why Choose This Calculator for enVVeno Medical Corporation (NVNO)?

  • User-Friendly Interface: Perfect for both newcomers and seasoned professionals.
  • Customizable Inputs: Adjust parameters easily to suit your financial analysis.
  • Real-Time Feedback: Observe immediate changes in enVVeno’s valuation as you tweak inputs.
  • Preloaded Data: Comes with enVVeno’s actual financial figures for swift evaluations.
  • Relied Upon by Experts: Favored by investors and analysts for making well-informed choices.

Who Should Use This Product?

  • Healthcare Investors: Develop comprehensive valuation models for assessing enVVeno Medical Corporation (NVNO) investments.
  • Medical Device Companies: Evaluate market scenarios to inform strategic decisions within the industry.
  • Consultants and Advisors: Deliver precise valuation insights for clients interested in enVVeno Medical Corporation (NVNO).
  • Students and Educators: Utilize real-time data to enhance financial modeling skills and knowledge.
  • Biomedical Enthusiasts: Gain insights into how companies like enVVeno Medical Corporation (NVNO) are valued in the healthcare sector.

What the Template Contains

  • Historical Data: Includes enVVeno Medical Corporation’s (NVNO) past financials and baseline forecasts.
  • DCF and Levered DCF Models: Detailed templates to calculate enVVeno Medical Corporation’s (NVNO) intrinsic value.
  • WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
  • Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
  • Quarterly and Annual Statements: A complete breakdown of enVVeno Medical Corporation’s (NVNO) financials.
  • Interactive Dashboard: Visualize valuation results and projections dynamically.

Es wurden keine passenden Produkte gefunden.